{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T19:02:38Z","timestamp":1774465358926,"version":"3.50.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1016\/j.bcp.2010.08.022","type":"journal-article","created":{"date-parts":[[2010,9,4]],"date-time":"2010-09-04T10:41:48Z","timestamp":1283596908000},"page":"1700-1707","source":"Crossref","is-referenced-by-count":92,"title":["Pregnane-X-receptor mediates the anti-inflammatory activities of rifaximin on detoxification pathways in intestinal epithelial cells"],"prefix":"10.1016","volume":"80","author":[{"given":"Andrea","family":"Mencarelli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Migliorati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miriam","family":"Barbanti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabrina","family":"Cipriani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Palladino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleonora","family":"Distrutti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Renga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Fiorucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2010.08.022_bib0005","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/00042737-200306000-00001","article-title":"New developments in aetiological mechanisms of inflammatory bowel disease","volume":"15","author":"Scholmerich","year":"2003","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.bcp.2010.08.022_bib0010","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/00001574-200407000-00003","article-title":"Update in inflammatory bowel disease pathogenesis","volume":"20","author":"Rogler","year":"2004","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.bcp.2010.08.022_bib0015","first-page":"127","article-title":"Etiology and pathogenesis of inflammatory bowel disease","volume":"51","author":"Schmidt","year":"2005","journal-title":"Minerva Gastroenterol Dietol"},{"key":"10.1016\/j.bcp.2010.08.022_bib0020","doi-asserted-by":"crossref","first-page":"895","DOI":"10.7326\/0003-4819-143-12-200512200-00007","article-title":"New concepts in the pathophysiology of inflammatory bowel disease","volume":"143","author":"Bamias","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bcp.2010.08.022_bib0025","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1586\/14737159.6.3.345","article-title":"Role of genes, the environment and their interactions in the etiology of inflammatory bowel diseases","volume":"6","author":"Ahmed","year":"2006","journal-title":"Expert Rev Mol Diagn"},{"key":"10.1016\/j.bcp.2010.08.022_bib0030","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/ncpgasthep0545","article-title":"Loss of detoxification in inflammatory bowel disease","volume":"3","author":"Langmann","year":"2006","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"10.1016\/j.bcp.2010.08.022_bib0035","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1042\/bj2400027","article-title":"Multiple forms of cytochrome P-450 related to forms induced marginally by phenobarbital. Differences in structure and in the metabolism of alkoxyresorufins","volume":"240","author":"Wolf","year":"1986","journal-title":"Biochem J"},{"key":"10.1016\/j.bcp.2010.08.022_bib0040","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3109\/03602539409029789","article-title":"Role of human cytochromes P450 in the metabolic activation of chemical carcinogens and toxins","volume":"26","author":"Gonzalez","year":"1994","journal-title":"Drug Metab Rev"},{"key":"10.1016\/j.bcp.2010.08.022_bib0045","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1472-6904-5-4","article-title":"Distribution of cytochrome P450 2C, 2E1, 3A4, and 3A5 in human colon mucosa","volume":"5","author":"Bergheim","year":"2005","journal-title":"BMC Clin Pharmacol"},{"key":"10.1016\/j.bcp.2010.08.022_bib0050","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/bdd.518","article-title":"Comparative cytochrome P450-1A1, -2A6, -2B6, -2C, -2D6, -2E1, -3A5 and -4B1 expressions in human larynx tissue analysed at mRNA level","volume":"27","author":"Sarikaya","year":"2006","journal-title":"Biopharm Drug Dispos"},{"key":"10.1016\/j.bcp.2010.08.022_bib0055","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/S1359-6446(04)03061-2","article-title":"Orphan nuclear receptor-mediated xenobiotic regulation in drug metabolism","volume":"9","author":"Xie","year":"2004","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.bcp.2010.08.022_bib0060","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1136\/gut.41.6.731","article-title":"Human colonocyte detoxification","volume":"41","author":"Roediger","year":"1997","journal-title":"Gut"},{"key":"10.1016\/j.bcp.2010.08.022_bib0065","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1210\/er.2001-0038","article-title":"The nuclear pregnane X receptor: a key regulator of xenobiotic metabolism","volume":"23","author":"Kliewer","year":"2002","journal-title":"Endocr Rev"},{"key":"10.1016\/j.bcp.2010.08.022_bib0070","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1210\/me.2002-0421","article-title":"Genetic profiling defines the xenobiotic gene network controlled by the nuclear receptor pregnane X receptor","volume":"17","author":"Rosenfeld","year":"2003","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.bcp.2010.08.022_bib0075","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1073\/pnas.0409481102","article-title":"Pregnane X receptor prevents hepatorenal toxicity from cholesterol metabolites","volume":"102","author":"Sonoda","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bcp.2010.08.022_bib0080","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1053\/j.gastro.2004.04.019","article-title":"Loss of detoxification in inflammatory bowel disease: dysregulation of pregnane X receptor target genes","volume":"127","author":"Langmann","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bcp.2010.08.022_bib0085","first-page":"G1114","article-title":"Pregnane X receptor activation ameliorates DSS-induced inflammatory bowel disease via inhibition of NF-\u03baB target gene expression","volume":"292","author":"Shah","year":"2007","journal-title":"Am J Physiol"},{"key":"10.1016\/j.bcp.2010.08.022_bib0090","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1016\/S0092-8674(02)00703-1","article-title":"Missing pieces in the NF-\u03baB puzzle","volume":"109","author":"Ghosh","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2010.08.022_bib0095","doi-asserted-by":"crossref","first-page":"17882","DOI":"10.1074\/jbc.M601302200","article-title":"Role of NF-\u03baB in regulation of PXR-mediated gene expression, a mechanism for the suppression of cytochrome P-4503A4 by pro-inflammatory agents","volume":"281","author":"Gu","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2010.08.022_bib0100","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.3109\/03602539709002246","article-title":"Regulation of cytochromes P450 during inflammation and infection","volume":"29","author":"Morgan","year":"1997","journal-title":"Drug Metab Rev"},{"key":"10.1016\/j.bcp.2010.08.022_bib0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/pr.109.002014","article-title":"Xenobiotic, bile acid, and cholesterol transporters: function and regulation","volume":"62","author":"Klaassen","year":"2010","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.bcp.2010.08.022_bib0110","doi-asserted-by":"crossref","first-page":"5733","DOI":"10.4049\/jimmunol.161.10.5733","article-title":"A novel model of inflammatory bowel disease: mice deficient for the multiple drug resistance gene, mdr1a, spontaneously develop colitis","volume":"161","author":"Panwala","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.bcp.2010.08.022_bib0115","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1053\/gast.2003.50010","article-title":"Association between the C3435T MDR1 gene polymorphism and susceptibility for ulcerative colitis","volume":"124","author":"Schwab","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bcp.2010.08.022_bib0120","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1086\/379927","article-title":"MDR1 Ala893 polymorphism is associated with inflammatory bowel disease","volume":"73","author":"Brant","year":"2003","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.bcp.2010.08.022_bib0125","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1124\/jpet.107.121913","article-title":"Rifaximin is a gut-specific human pregnane X receptor activator","volume":"322","author":"Ma","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bcp.2010.08.022_bib0130","doi-asserted-by":"crossref","first-page":"561","DOI":"10.2174\/1389200023337054","article-title":"The cytochrome P450 superfamily: biochemistry, evolution and drug metabolism in humans","volume":"3","author":"Danielson","year":"2002","journal-title":"Curr Drug Metab"},{"key":"10.1016\/j.bcp.2010.08.022_bib0135","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1042\/bj2860383","article-title":"Purification and characterization of eight glutathione S-transferase isoenzymes of hamster. Comparison of subunit composition of enzymes from liver, kidney, testis, pancreas and trachea","volume":"286","author":"Bogaards","year":"1992","journal-title":"Biochem J"},{"key":"10.1016\/j.bcp.2010.08.022_bib0140","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/ijc.22156","article-title":"SULT1A1 genotype and susceptibility to colorectal cancer","volume":"120","author":"Lilla","year":"2007","journal-title":"Int J Cancer"},{"key":"10.1016\/j.bcp.2010.08.022_bib0145","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1136\/gut.52.5.759","article-title":"Multidrug resistance 1 gene (P-glycoprotein 170): an important determinant in gastrointestinal disease?","volume":"52","author":"Ho","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.bcp.2010.08.022_bib0150","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1373\/49.2.230","article-title":"Real-time reverse transcription-PCR expression profiling of the complete human ATP-binding cassette transporter superfamily in various tissues","volume":"49","author":"Langmann","year":"2003","journal-title":"Clin Chem"},{"key":"10.1016\/j.bcp.2010.08.022_bib0155","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1586\/14787210.3.2.201","article-title":"Rifaximin: a nonabsorbable rifamycin antibiotic for use in nonsystemic gastrointestinal infections","volume":"3","author":"Gerard","year":"2005","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.bcp.2010.08.022_bib0160","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1159\/000081991","article-title":"Rifaximin: in vitro and in vivo antibacterial activity","volume":"51","author":"Jiang","year":"2005","journal-title":"Chemotherapy"},{"key":"10.1016\/j.bcp.2010.08.022_bib0165","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1179\/joc.2008.20.2.186","article-title":"Effects of rifaximin on bacterial virulence mechanisms at supra- and sub-inhibitory concentrations","volume":"20","author":"Debbia","year":"2008","journal-title":"J Chemother"},{"key":"10.1016\/j.bcp.2010.08.022_bib0170","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1159\/000068362","article-title":"Inhibition of intestinal bacterial translocation with rifaximin modulates lamina propria monocytic cells reactivity and protects against inflammation in a rodent model of colitis","volume":"66","author":"Fiorucci","year":"2002","journal-title":"Digestion"},{"key":"10.1016\/j.bcp.2010.08.022_bib0175","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1056\/NEJMoa0907893","article-title":"Rifaximin treatment in hepatic encephalopathy","volume":"362","author":"Bass","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bcp.2010.08.022_bib0180","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1159\/000081990","article-title":"Rifaximin, a poorly absorbed antibiotic: pharmacology and clinical potential","volume":"51","author":"Scarpignato","year":"2005","journal-title":"Chemotherapy"},{"key":"10.1016\/j.bcp.2010.08.022_bib0185","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/clpt.2010.2","article-title":"Nuclear receptors, inflammation, and liver disease: insights for cholestatic and fatty liver diseases","volume":"87","author":"Arrese","year":"2010","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.bcp.2010.08.022_bib0190","first-page":"435","article-title":"Molecular control of immune\/inflammatory responses: interactions between nuclear factor-\u03baB and steroid receptor-signaling pathways","volume":"20","author":"McKay","year":"1999","journal-title":"Endocr Rev"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295210006520?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295210006520?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,3]],"date-time":"2023-06-03T05:00:28Z","timestamp":1685768428000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295210006520"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":38,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S0006295210006520"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2010.08.022","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]}}}